585 related articles for article (PubMed ID: 18301313)
41. Simultaneous hemodialysis during coronary angiography fails to prevent radiocontrast-induced nephropathy in chronic renal failure.
Frank H; Werner D; Lorusso V; Klinghammer L; Daniel WG; Kunzendorf U; Ludwig J
Clin Nephrol; 2003 Sep; 60(3):176-82. PubMed ID: 14524580
[TBL] [Abstract][Full Text] [Related]
42. Incidence of contrast-induced nephropathy in patients with chronic renal insufficiency undergoing multidetector computed tomographic angiography treated with preventive measures.
El-Hajjar M; Bashir I; Khan M; Min J; Torosoff M; DeLago A
Am J Cardiol; 2008 Aug; 102(3):353-6. PubMed ID: 18638601
[TBL] [Abstract][Full Text] [Related]
43. Comparative investigation of i.v. iohexol and iopamidol: effect on renal function in low-risk outpatients undergoing CT.
Dillman JR; al-Hawary M; Ellis JH; Cohan RH; Kaza R; Myles JD; Khalatbari S; Francis IR
AJR Am J Roentgenol; 2012 Feb; 198(2):392-7. PubMed ID: 22268183
[TBL] [Abstract][Full Text] [Related]
44. Nephrotoxic effects in high-risk patients undergoing angiography.
Aspelin P; Aubry P; Fransson SG; Strasser R; Willenbrock R; Berg KJ;
N Engl J Med; 2003 Feb; 348(6):491-9. PubMed ID: 12571256
[TBL] [Abstract][Full Text] [Related]
45. The role of N-acetylcysteine in the prevention of contrast-induced nephrotoxicity.
Sandhu C; Belli AM; Oliveira DB
Cardiovasc Intervent Radiol; 2006; 29(3):344-7. PubMed ID: 16502177
[TBL] [Abstract][Full Text] [Related]
46. Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study.
Huber W; Ilgmann K; Page M; Hennig M; Schweigart U; Jeschke B; Lutilsky L; Weiss W; Salmhofer H; Classen M
Radiology; 2002 Jun; 223(3):772-9. PubMed ID: 12034949
[TBL] [Abstract][Full Text] [Related]
47. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.
Boccalandro F; Amhad M; Smalling RW; Sdringola S
Catheter Cardiovasc Interv; 2003 Mar; 58(3):336-41. PubMed ID: 12594698
[TBL] [Abstract][Full Text] [Related]
48. Iomeprol versus iopamidol in contrast-enhanced computed tomography of thoracic and abdominal organs.
Valentini AL; Tartaglione T; Monti L; Marano P
Eur J Radiol; 1994 May; 18 Suppl 1():S88-92. PubMed ID: 8020525
[TBL] [Abstract][Full Text] [Related]
49. Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial.
Rudnick MR; Davidson C; Laskey W; Stafford JL; Sherwin PF;
Am Heart J; 2008 Oct; 156(4):776-82. PubMed ID: 18946896
[TBL] [Abstract][Full Text] [Related]
50. Contrast medium-induced acute kidney injury: comparison of intravenous and intraarterial administration of iodinated contrast medium.
Karlsberg RP; Dohad SY; Sheng R;
J Vasc Interv Radiol; 2011 Aug; 22(8):1159-65. PubMed ID: 21570871
[TBL] [Abstract][Full Text] [Related]
51. 80-kV pulmonary CT angiography with 40 mL of iodinated contrast material in lean patients: comparison of vascular enhancement with iodixanol (320 mg I/mL)and iomeprol (400 mg I/mL).
Faggioni L; Neri E; Sbragia P; Pascale R; D'Errico L; Caramella D; Bartolozzi C
AJR Am J Roentgenol; 2012 Dec; 199(6):1220-5. PubMed ID: 23169711
[TBL] [Abstract][Full Text] [Related]
52. Iodixanol vs iopamidol in intravenous DSA of the abdominal aorta and lower extremity arteries: a comparative phase-III trial.
Fischbach R; Landwehr P; Lackner K; Nossen JO; Heindel W; Berg KJ; Eichhorn G; Jacobsen TF
Eur Radiol; 1996; 6(1):9-13. PubMed ID: 8797943
[TBL] [Abstract][Full Text] [Related]
53. Effectiveness of theophylline in preventing contrast-induced nephropathy after coronary angiographic procedures.
Bilasy ME; Oraby MA; Ismail HM; Maklady FA
J Interv Cardiol; 2012 Aug; 25(4):404-10. PubMed ID: 22612071
[TBL] [Abstract][Full Text] [Related]
54. [Effectiveness of nephroprotection by the selection of contrast media used during vascular interventions in patients with chronic renal failure?].
Schönefeld E; Höwler S; Osada N; Torsello G
Zentralbl Chir; 2011 Oct; 136(5):426-30. PubMed ID: 22009540
[TBL] [Abstract][Full Text] [Related]
55. Comparison of a low-osmolar contrast medium, iopamidol, and an iso-osmolar contrast medium, iodixanol, in MDCT coronary angiography.
Ozbulbul NI; Yurdakul M; Tola M
Coron Artery Dis; 2010 Nov; 21(7):414-9. PubMed ID: 20671550
[TBL] [Abstract][Full Text] [Related]
56. No increased risk for contrast-induced nephropathy after multiple CT perfusion studies of the brain with a nonionic, dimeric, iso-osmolal contrast medium.
Langner S; Stumpe S; Kirsch M; Petrik M; Hosten N
AJNR Am J Neuroradiol; 2008 Sep; 29(8):1525-9. PubMed ID: 18524974
[TBL] [Abstract][Full Text] [Related]
57. Relationship of proximal fixation to renal dysfunction in patients undergoing endovascular aneurysm repair.
Mehta M; Cayne N; Veith FJ; Darling RC; Roddy SP; Paty PS; Ozsvath KJ; Kreienberg PB; Chang BB; Shah DM
J Cardiovasc Surg (Torino); 2004 Aug; 45(4):367-74. PubMed ID: 15365517
[TBL] [Abstract][Full Text] [Related]
58. Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients.
Feldkamp T; Baumgart D; Elsner M; Herget-Rosenthal S; Pietruck F; Erbel R; Philipp T; Kribben A
Clin Nephrol; 2006 Nov; 66(5):322-30. PubMed ID: 17140161
[TBL] [Abstract][Full Text] [Related]
59. Iodixanol versus iopromide in patients with renal insufficiency undergoing coronary angiography with or without PCI.
Zhang J; Jiang Y; Rui Q; Chen M; Zhang N; Yang H; Zhou Y
Medicine (Baltimore); 2018 May; 97(18):e0617. PubMed ID: 29718868
[TBL] [Abstract][Full Text] [Related]
60. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Briguori C; Airoldi F; D'Andrea D; Bonizzoni E; Morici N; Focaccio A; Michev I; Montorfano M; Carlino M; Cosgrave J; Ricciardelli B; Colombo A
Circulation; 2007 Mar; 115(10):1211-7. PubMed ID: 17309916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
